McElhenny Sheffield Capital Management LLC purchased a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 131,327 shares of the company’s stock, valued at approximately $13,201,000. iShares U.S. Pharmaceuticals ETF comprises about 3.1% of McElhenny Sheffield Capital Management LLC’s portfolio, making the stock its 7th biggest holding.
A number of other institutional investors also recently made changes to their positions in IHE. AdvisorNet Financial Inc acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at $5,224,000. Tidal Investments LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at about $3,716,000. Schuylkill Financial LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at about $992,000. Bank of America Corp DE lifted its holdings in iShares U.S. Pharmaceuticals ETF by 2.8% in the 1st quarter. Bank of America Corp DE now owns 456,606 shares of the company’s stock valued at $39,579,000 after purchasing an additional 12,565 shares in the last quarter. Finally, Compass Financial Management LLC purchased a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at about $565,000.
iShares U.S. Pharmaceuticals ETF Price Performance
iShares U.S. Pharmaceuticals ETF stock opened at $111.03 on Monday. iShares U.S. Pharmaceuticals ETF has a 12-month low of $79.82 and a 12-month high of $111.98. The stock has a market capitalization of $1.73 billion, a P/E ratio of 33.66 and a beta of 0.48. The firm’s 50-day moving average is $103.09 and its two-hundred day moving average is $95.85.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Featured Articles
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report).
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
